LY2835219 mesylate/ LIDE PHARMA- Factory supply / Best price

Min.Order / FOB Price:Get Latest Price

1 Gram	FOB Price: USD 10.0000

1 Gram

FOB Price: USD 10.0000

Min.Order :1 Gram
Purity: 99%min.
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

LY2835219 mesylate Bemaciclib mesylate Abemaciclib mesylate

Quick Details

Appearance:White powder
Application:LY2835219 is an orally-bioavailable dual inhibitor of cyclin-dependent kinase 4 (CDK4) and CDK6 (IC50s = 2 and 10 nM, respectively). Through this mechanism, it blocks phosphorylation of retinoblastoma
PackAge:1g/Al-foiled bag; 10g/Al-foiled bag; 100g/Al-foiled bag; 1kg/Al-foiled bag or Al-tin
ProductionCapacity:10|Metric Ton|Day
Storage:Storage: In well-closed container, protected from light and in cool & dry place.
Transportation:By air, by courier(FedEx/DHL/EMS),by sea

Superiority:

Advantage :

LIDE PHARMACEUTICALS LIMITED is a professional chemicals and APIs leading manufacturer in China. Our core business line covers APIs, Intermediates, etc.

We are specialized in chemical synthesis, process development of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and rare chemicals.

We also accept custom synthesis project and contract research services like CRO, CMO and CDMO.

R&D strength:

We have well equipped chemicals and instrumental laboratories with modern instruments such as HPLC,GC,IR,UV,NMR,LC-MS etc.

At present, we are selling it with good discount for immediate delivery ! BOOKING TO HASTEN !

Details:

(1) Company profile:

Company profile: Lide Pharmaceuticals Limited

Main products: APIs; Intermediate and other fine chemical products; Piperazine series; Custom Synthesis; CRO; CMO; CDMO.

Main Markets: North America; South America; Eastern Europe; Southeast Asia; Africa Oceania; Mid East; Eastern Asia; Western Europe, etc.

(2) Product:

Product Name: LY2835219 mesylate; Bemaciclib mesylate; Abemaciclib mesylate

CAS No.: 1231930-82-7

Molecular Formula: C28H36F2N8O3S

Molecular Weight: 602.69

Appearance: White crystalline powder

Specification: 99%min.

(3) Application:

LY2835219 is an orally-bioavailable dual inhibitor of cyclin-dependent kinase 4 (CDK4) and CDK6 (IC50s = 2 and 10 nM, respectively). Through this mechanism, it blocks phosphorylation of retinoblastoma protein, resulting in arrest of cell cycling in the G1 phase. LY2835219 has antitumor action against xenografts when used alone or in combination with other chemotherapeutic compounds.[Cayman Chemical]

View All

Visit Store